Press release
Whole-exome-sequencing Market Profiles: Segment Size, Growth, and Trends Forecast (2024-2031) - Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc.
DataM Intelligence has released a new research report on the Whole Exome Sequencing [WES] market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits, gross margins, and strategic decisions in the global market. The report is enriched with tables, charts, and infographics for a clear presentation of the findings.Global Whole Exome Sequencing [WES] Market reached USD 1.1 Billion and is expected to reach US$ 4.2 Billion by 2031, growing with a CAGR of 18.6% during the forecast period 2024-2031.
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/whole-exome-sequencing-market
Whole Exome Sequencing (WES) is a genomic technique used to sequence all the protein-coding regions, or exons, of an individual's DNA. Since exons comprise approximately 1-2% of the human genome but account for a significant portion of known disease-related variants, WES is a valuable tool in clinical and research settings. This method allows for the identification of genetic mutations associated with various conditions, including hereditary diseases, cancers, and developmental disorders. The process involves extracting DNA, preparing it for sequencing, and using high-throughput sequencing technologies to analyze the exonic regions. WES provides a cost-effective and efficient means to explore the genetic basis of diseases, leading to better diagnosis, personalized medicine, and insights into the underlying biology of complex conditions. However, interpreting the vast amount of data generated can be challenging and often requires advanced bioinformatics tools and expertise.
List of the Key Players in the Whole Exome Sequencing [WES] Market:
Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Macrogen Inc., Beijing Genomics Institute, Ambry Genetics Corp., Eurofins Scientific Group, F. Hoffmann-La Roche AG, GENEWIZ Inc., Pacific Biosciences of California Inc.,
Key Developments:
For example, on May 5, 2022, Illumina announced a partnership with Deerfield Management to accelerate drug development initiatives. Additionally, on August 3, 2022, Bio-Rad completed the acquisition of Curiosity Diagnostics.
Research Process:
Both primary and secondary data sources have been used in the global Whole Exome Sequencing [WES] Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Segment Covered in the Whole Exome Sequencing [WES] Market:
By Product & Services: Systems, Kits (Library Preparation Kits, Target Enrichment Kits, Others), Services (Sequencing Services, Data Analysis (Bioinformatics) Services, Others Services).
By Technology: Second-generation Sequencing (Sequencing, by Synthesis (SBS), Sequencing, by Hybridization and Ligation (SBL)), Third-generation Sequencing.
By Application: Drug Discovery and Development, Diagnostics, Personalized Medicine, Others.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/whole-exome-sequencing-market
Regional Analysis:
➣ North America (US, Canada, Mexico)
➣ Europe (Germany, Russia, UK, France, Italy, Spain, Rest of Europe)
➣ Asia-Pacific (China, India, Japan, Australia, Rest of Asia Pacific)
➣ South America (Brazil, Argentina, Rest of South America)
➣ Middle East and Africa
**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**
Chapter Outline:
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Whole Exome Sequencing [WES] market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Whole Exome Sequencing [WES] Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The global Whole Exome Sequencing [WES] market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Whole Exome Sequencing [WES] Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/whole-exome-sequencing-market
The Research Report Offers Answers To The Following Questions:
☛ What is the expected growth rate of the global market for the forecast period?
☛ What are the key driving factors that are responsible to shape the fate of the Whole Exome Sequencing [WES] market during the forecast period?
☛ What will be the overall size of the market during the analysis period?
☛ What are the prominent market trends which influence the development of the Whole Exome Sequencing [WES] market across various regions?
☛ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?
☛ What are the challenges and threats that are likely to act as a barrier to the growth of the Whole Exome Sequencing [WES] market?
☛ What are the major opportunities that the companies can get to attain success in the world?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Whole-exome-sequencing Market Profiles: Segment Size, Growth, and Trends Forecast (2024-2031) - Illumina Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc. here
News-ID: 3696328 • Views: …
More Releases from DataM Intelligence 4market Research LLP

Pharmaceuticals Market to Reach US$ 3.18 Trillion by 2033, Fueled by Biologics a …
According to DataM Intelligence, the global pharmaceuticals market size reached US$ 1,740.44 Billion in 2024 and is expected to reach US$ 3,178.63 Billion by 2033, growing at a CAGR of 7.0% during the forecast period 2025-2033.
The Pharmaceuticals Market refers to the industry involved in the research, development, production, and distribution of drugs and medications. It includes prescription drugs, over-the-counter (OTC) products, branded and generic drugs, and treatments across various therapeutic…

Neurostimulation Devices Market to Reach US$ 17.82 Billion by 2033, Fueled by AI …
According to DataM Intelligence, the global neurostimulation devices market size reached US$ 6.99 billion in 2024 from US$ 6.36 billion in 2023 and is expected to reach US$ 17.82 Billion by 2033, growing at a CAGR of 11.1% during the forecast period 2025-2033.
The neurostimulation devices market encompasses implantable and external devices designed to modulate neural activity for therapeutic purposes, addressing conditions from chronic pain and movement disorders to epilepsy and…

Rare Disease Therapeutics Market to Reach US$ 495.27 Billion by 2033, Growing at …
According to DataM Intelligence, the global rare disease therapeutics market reached US$ 135.88 billion in 2023, with a rise of US$ 154.64 billion in 2024, and is expected to reach US$ 495.27 billion by 2033, growing at a CAGR of 13.8% from 2025 to 2033.
The Rare Disease Therapeutics Market refers to the sector focused on developing and distributing treatments for rare diseases, which affect a small percentage of the…

Lymphedema Treatment Market is expected to reach US$ 2,029.90 million by 2033 | …
Global lymphedema market reached US$ 989.85 million in 2024 and is expected to reach US$ 2,029.90 million by 2033, growing at a CAGR of 8.8 % during the forecast period of 2025-2033.
The Lymphedema Market focuses on the diagnosis, treatment, and management of lymphedema, a chronic condition characterized by abnormal accumulation of lymphatic fluid, typically in the arms or legs, due to lymphatic system dysfunction. It often arises as a complication…
More Releases for Sequencing
Sequencing Reagents Market Report 2024 - Sequencing Reagents Market Trends And S …
"The Business Research Company recently released a comprehensive report on the Global Sequencing Reagents Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Sequencing the Future: Next Generation Sequencing Market Projections (2023-2033)
The global Next-generation Sequencing Market was over 8.5 billion in 2022 and it is anticipated to grow at a CAGR of over 18.2% during the forecast period.
Market Outlook:
The Next Generation Sequencing (NGS) market is set for an extraordinary trajectory of growth and innovation from 2023 to 2033. This decade is poised to witness a paradigm shift in genomics and molecular biology, with NGS technologies playing a central role in reshaping…
Sequencing Reagents Market - Elevating Accuracy, Inspiring Discovery: Revolution …
Newark, New Castle, USA - new report, titled Sequencing Reagents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sequencing Reagents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sequencing Reagents market. The report offers an overview of the market, which…
Microbiome Sequencing Services Market By Technology (Sequencing By Synthesis (SB …
Microbiome are the group of microorganisms that grow on saliva, skin layers, conjunctiva, oral mucosa and the gastrointestinal tract. Microbiome sequencing is the study and analysis of microbes groups located outside and inside of the human body to gain knowledge about human microbes.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00004419/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
Baseclear B.V.
Clinical-Microbiomics A/S
Molzym GmbH & Co. Kg
Zymo Research Corp.
Rancho Biosciences
Microbiome Therapeutics, LLC.
Microbiome Insights Inc.
Openbiome
Resphera Biosciences, LLC.
Ubiome, Inc.
The report covers key developments…
Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com
Get Research Sample PDF at https://www.search4research.com/request-sample/113582/
Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,…
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period.
Metagenomics, is a field where genomic analysis of microbial DNA…